Company Name
  • About Us
    • Company overview
    • Management Team
    • Board of Directors
    • Kinarus story
  • Programs and Pipeline
    • Therapeutic approach
    • Development Pipeline
  • Disease Areas
    • Age-Related Macular Degeneration
    • Covid-19
    • Idiopathic Pulmonary Fibrosis
  • Investors and Media
    • Stock Information
    • Financial News
    • Reports & Presentations
    • Financial Calendar
    • Corporate Governance
    • IR Contact & Service
  • Contact

  • Stock Information
    • Stock Quote and Chart
    • Listing Information
  • Analyst Coverage
  • Financial News
    • Ad-hoc Releases
    • Corporate News
  • Reports & Presentations
    • Presentations & Webcasts
    • Annual Reports
    • Half year report
    • Perfect Holding SA – Historical Information
  • Financial Calendar
  • Corporate Governance
    • Overview
  • IR Contact & Service
    • IR Contact
    • Contact Form
Kinarus

Company research


 

Click on headline below to download research
Making p38 MAP kinase inhibition viable

KINARUS AG
Technologiepark Basel
Hochbergerstrasse 60C
4057 Basel

+41 616332971
info@kinarus.com LinkedIn

Who we are
Kinarus AG is a biopharmaceutical company headquartered in Basel, Switzerland.

Links
Disclaimer Privacy policy Cookie policy Imprint